Radiopharm Theranostics (ASX:RAD) Insider Riccardo Canevari Buys 1,500,000 Shares of Stock

Radiopharm Theranostics Limited (ASX:RAD) insider Riccardo Canevari purchased 1,500,000 shares of Radiopharm Theranostics stock in a transaction that occurred on Thursday, October 30th. The shares were purchased at an average price of A$0.03 per share, for a total transaction of A$37,500.00.

Radiopharm Theranostics Stock Performance

The stock has a market capitalization of $60.78 million, a PE ratio of -0.19 and a beta of 0.82.

Radiopharm Theranostics Company Profile

Radiopharm Theranostics Limited engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs. It is developing its lead products comprising Nano-mAbs and AVB6 Integrin. The company was incorporated in 2021 and is based in Carlton, Australia.